Antitumor effects of radionuclide treatment using α-emitting meta-(211)At-astato-benzylguanidine in a PC12 pheochromocytoma model

PURPOSE: Therapeutic options for patients with malignant pheochromocytoma are currently limited, and therefore new treatment approaches are being sought. Targeted radionuclide therapy provides tumor-specific systemic treatments. The β-emitting radiopharmaceutical meta-(131)I-iodo-benzylguanidine ((1...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur J Nucl Med Mol Imaging
Auteurs principaux: Ohshima, Yasuhiro, Sudo, Hitomi, Watanabe, Shigeki, Nagatsu, Kotaro, Tsuji, Atsushi B., Sakashita, Tetsuya, Ito, Yoichi M., Yoshinaga, Keiichiro, Higashi, Tatsuya, Ishioka, Noriko S.
Format: Artigo
Langue:Inglês
Publié: Springer Berlin Heidelberg 2018
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915519/
https://ncbi.nlm.nih.gov/pubmed/29350258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3919-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires